GC Therapeutics
Cambridge, Massachusetts, United States · Biotechnology, Health Care, Therapeutics
GC Therapeutics is a biopharmaceutical company focused on advancing cell therapy-based medicines. It utilizes an induced pluripotent stem cell programming platform, TFome™, which incorporates synthetic biology, gene editing, cell engineering, and machine learning. The company aims to tackle the complexities of therapeutic development and scaling in cell therapy to enhance patient access to treatme
Key facts
- Headquarters
- Cambridge, Massachusetts, United States
- Employees
- 38
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- www.gc-tx.com
- Company page
Recent activity at GC Therapeutics
- : GC Therapeutics Appoints Stefan Irion, MD as Chief Scientific Officer
- : GC Therapeutics raised $65M in a Series A funding round led by Cormorant Asset Management to expand operations and develop cell therapies for various diseases.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
GC Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2024 | Series A | $65.0M |
Leadership
- Alex Ng, PhD, Chief Innovation Officer
- Stefan Irion, MD, Chief Scientific Officer
- Parastoo Khoshakhlagh, Chief Executive Officer
- Brett Losen, Operations Manager
- Cory Smith, Founder
Verified email and direct lines for GC Therapeutics’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
GC Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to GC Therapeutics
- Candel Therapeutics · Biotechnology, Health Care, Therapeutics
- KALA BIO, Inc. · Biotechnology, Health Care, Therapeutics
- DiaMedica Therapeutics · Biotechnology, Health Care, Therapeutics
- Epicrispr Biotechnologies · Biotechnology, Health Care, Therapeutics
- Korsana Biosciences · Biotechnology, Health Care, Therapeutics
About GC Therapeutics: questions and answers
What does GC Therapeutics do?
GC Therapeutics is a biopharmaceutical company focused on advancing cell therapy-based medicines. It utilizes an induced pluripotent stem cell programming platform, TFome™, which incorporates synthetic biology, gene editing, cell engineering, and machine learning. The company aims to tackle the complexities of therapeutic development and scaling in cell therapy to enhance patient access to treatme
Where is GC Therapeutics headquartered?
GC Therapeutics is headquartered in Cambridge, Massachusetts, United States.
How many employees does GC Therapeutics have?
GC Therapeutics has about 38 employees.
Has GC Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for GC Therapeutics. The most recent, Series A of $65.0M, was in Sep 2024.
Who leads GC Therapeutics?
Parastoo Khoshakhlagh is a Chief Executive Officer at GC Therapeutics.
What is the latest news on GC Therapeutics?
On May 5, 2026, GC Therapeutics Appoints Stefan Irion, MD as Chief Scientific Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy